Validity: Valid only for option purchased
But they are not the same drug, and the differences between them are now clearer than ever thanks to the landmark SURMOUNT-5 head-to-head clinical trial , the first study to compare them directly in the same patient population
Health markers, including blood pressure, blood sugar, cholesterol, and inflammatory markers, have typically improved substantially
Sleep timing affects both therapies
However, for peri-menopausal women , GLP-1 medications can come with hidden risksparticularly when weight loss occurs without adequate nutrition and strength training support
The Rise of GLP-1 and Why Taste Is Being Reconsidered The global market for GLP-1 therapies continues to expand rapidly and is forecast to reach by $33.26 billion by 2030